Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer. [electronic resource]
Producer: 20040812Description: 1141-51 p. digitalISSN:- 1460-2105
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Breast Neoplasms -- chemistry
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Epirubicin -- administration & dosage
- Female
- Gene Amplification
- Gene Expression Regulation, Neoplastic
- Genes, erbB-2
- Humans
- In Situ Hybridization, Fluorescence
- Middle Aged
- Neoplasm Staging
- Paclitaxel -- pharmacology
- Predictive Value of Tests
- Prognosis
- Randomized Controlled Trials as Topic
- Receptor, ErbB-2 -- analysis
- Retrospective Studies
- Treatment Outcome
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.